Journal

Nucleic acid therapeutics
ISSN: 2159-3345
Titre abrégé: Nucleic Acid Ther
Pays: United States
ID NLM: 101562758

Informations de publication

Date de publication:
10 2021
Historique:
pubmed: 13 5 2021
medline: 14 1 2022
entrez: 12 5 2021
Statut: ppublish

Résumé

Stable isotope labeling (SIL) of active pharmaceutical ingredients (API) is a well-established technique for the accurate quantification of small-molecule drugs. As the scope of active ingredients is expanding into areas of larger molecules, such as oligonucleotides (ONs), the development of new quantification techniques is critical. Herein, we describe the analysis of a

Identifiants

pubmed: 33978476
doi: 10.1089/nat.2020.0915
doi:

Substances chimiques

Oligonucleotides 0
PCSK9 protein, human EC 3.4.21.-
Pcsk9 protein, mouse EC 3.4.21.-
Proprotein Convertase 9 EC 3.4.21.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

375-381

Auteurs

Rouven Stulz (R)

Oligonucleotide Discovery, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Department of Biosciences and Nutrition, Karolinska Institutet, NEO, S-14183 Huddinge, Sweden.

Fiona Milligan (F)

Bioanalysis Department, Charles River Laboratories, Elphinstone Research Centre, Tranent, United Kingdom.

Craig Stovold (C)

Integrated Bioanalysis, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, United Kingdom.

Iain Love (I)

Bioanalysis Department, Charles River Laboratories, Elphinstone Research Centre, Tranent, United Kingdom.

Roger Strömberg (R)

Department of Biosciences and Nutrition, Karolinska Institutet, NEO, S-14183 Huddinge, Sweden.

Shalini Andersson (S)

Oligonucleotide Discovery, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
DMPK, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.

Anders Dahlén (A)

Oligonucleotide Discovery, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH